Nanorobotics in Medicine Market (Product Type: NanoManipulator, Bio-nanorobotics, Magnetically Guided, and Bacteria-based; and Application: Nanomedicine, Biomedical, Drug Delivery, Medical Imaging, and Others)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Nanorobotics in Medicine market size was estimated at USD 4.9 billion in 2021 and is expected to surpass around USD 12.10 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 10.7% during the forecast period 2022 to 2030.

Nanorobots are machines made of nanoscale components. They generally measure 50100 nm in size and can be controlled at the nanometer or molecular scale. These devices are used for drug delivery, which is a critical aspect of medical treatment. Nanorobots can also perform precise and refined intracellular surgery. They can conduct various tasks such as actuating, sensing, signaling, information processing, and intelligence at the nanoscale level. Nanobots in medicine offer several opportunities such as artificial antibodies, artificial WBCs and RBCs, and antiviral nanobots.

Report Scope of the Nanorobotics in Medicine Market

Rise in Demand for Targeted Drug Delivery in Cancer Treatment Fueling Nanorobotics in Medicine Market Size

Nanobot medical technology can be guided to deliver a variety of payloads. In targeted drug delivery, nanorobots release a therapeutic payload after reaching a specific location in the body. Targeted drug delivery is used to release various types of loads such as enzymes, vaccines, drugs, and antigens in the body for the effective treatment of various diseases such as cancer, cardiovascular disease, and diabetes. It is widely used in cancer therapy to achieve excellent results.

Several research institutions involved in the nanorobotics systems market are using nanorobots to successfully deliver targeted drugs for cancer treatment. In January 2020, researchers from the King Abdullah University of Science and Technology created drug-coated iron nanowires (nanorobots). An iron oxide shell surrounds the iron core of iron-based nanowires. A magnetic field from outside is used to direct these drug-coated iron nanowires to the tumor's location. The anticancer drug, doxorubicin is released at the target site through a three-step cancer-killing mechanism, providing an effective option for cancer therapy.

Increase in Research and Development of Molecular Nanorobots

Molecular nanorobots are molecules that have been synthetically engineered. Researchers are developing molecular robots for use in the healthcare industry to perform diverse functions, including the collection of bacteria and tissue samples. This reduces tissue damage during minimally invasive surgery and improves diagnostics. Nanorobotics Tech, an Israel-based startup, has designed and demonstrated a new class of light-activated, unidirectional molecular nanomachines that can penetrate biological membranes by interacting with the lipid bilayer and focusing on specific elements of the cell surface.

Rise in Application of Nanomanipulators in R&D of Microchips and Microbiological Systems

Based on product type, the global nanorobotics in medicine market has been segmented into nanomanipulator, bio-nanorobotics, magnetically guided, and bacteria-based. The nanomanipulator segment is projected to dominate the market, accounting for more than 55% share of the market by the end of 2030. Nanomanipulators are capable of nanoscale positioning resolution and are used to produce precise structures. They are more capable than industrial manipulators. Nanomanipulators are among the first commercially available nanorobotics systems and are primarily used to manipulate atoms and molecules in nanorobot medicine. They are currently used in the development of transmission electron microscopy probes, carbon nanotubes, microchips, microbiological systems, and microelectromechanical systems (MEMS).

Increase in Development of Nanorobotics Medicine-based Drug Delivery Systems

In terms of application, the global nanorobotics in medicine market has been classified into nanomedicine, biomedical, drug delivery, medical imaging, and others. The nanomedicine segment is projected to dominate the market, accounting for more than 40% share of the market by the end of 2031. Rise in the development of drug delivery systems based on nanotechnology is driving the segment. Nanomedicine applications include vaccine development, drug delivery, wearable devices, diagnostic and imaging tools, and antibacterial agents. Nanomedicine is expected to facilitate the early detection of a wide range of diseases, thereby leading to the development of more effective drugs and improved devices.

Regional Outlook of Global Nanorobotics in Medicine Market

According to the recent nanorobotics in medicine market forecast, North America dominated the global market in 2021, and it is expected to maintain its position during the forecast period. Increase in funding for R&D in nanorobotics and rise in awareness regarding nanorobots in surgical care are driving the market in the region.

Europe is expected to record the second-largest share of the global market during the forecast period. Growth of the market in the region can be ascribed to increase in investments in the healthcare industry and rise in presence of research laboratories in many European countries such as Germany, France, and the U.K. The market in Asia Pacific is expected to grow at the highest CAGR during the forecast period, due to increase in investment for R&D in and expansion of the healthcare sector.

Analysis of Key Players in Global Nanorobotics in Medicine Market

The global nanorobotics in medicine market is fragmented, with a large number of large-scale vendors controlling majority of the market share. The report highlights trends in the virtual 3D nanorobots market and nanomedicine market. Key players are significantly investing in research and development activities to launch new products. Expansion of product portfolios and mergers and acquisitions are major strategies adopted by players. Imina Technologies, Thermo Fisher Scientific, Inc., Oxford Instruments plc, Klocke Nanotechnik GmbH, Kleindiek Nanotechnik GmbH, Bruker Corporation, SmarAct GmbH, Nanonics Imaging Ltd., Hummingbird Scientific, and Hitachi, Ltd. are prominent entities operating in this market.

Key Developments in Global Nanorobotics in Medicine Market

• In February 2021, Tescan Orsay Holding launched TESCAN Nanomanipulator, a fully integrated solution that supports lift-out as well as micro- and nanoscale manipulation under both room temperature and cryo conditions, on TESCAN SEM and FIB-SEM instruments
• In March 2018, JEOL Ltd. launched the JSM-IT200 Series InTouchScope - a new scanning electron microscope that includes innovative functions similar to the JSM-IT500 series - which are higher-end models of the InTouchScope series
• In March 2017, Oxford Instruments Asylum Research launched Surf Rider HQ-Series Atomic Force Microscopy (AFM) probes. The silicon probes can be used in all commercially available AFMs.

 Some of the prominent players in the Nanorobotics in Medicine Market include:

• Imina Technologies
• Thermo Fisher Scientific, Inc.
• Oxford Instruments plc
• Klocke Nanotechnik GmbH
• Kleindiek Nanotechnik GmbH
• Bruker Corporation
• SmarAct GmbH
• Nanonics Imaging Ltd.
• Hummingbird Scientific
• Hitachi, Ltd.
• Others

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Nanorobotics in Medicine market

• Product Type
  • Nanomanipulator
    • Electron Microscopy
    • Scanning Probe Microscopy
  • Bio-nanorobotics
  • Magnetically Guided
  • Bacteria-based
• Application
  • Nanomedicine
  • Biomedical
  • Drug Delivery
  • Medical Imaging
  • Others
• End-user
  • Pharmaceutical Industry
  • Research Institutes
  • Hospitals
  • Others

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Nanorobotics in Medicine industry analysis from 2022 to 2030 to identify the prevailing Nanorobotics in Medicine industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Nanorobotics in Medicine industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Nanorobotics in Medicine industry trends, key players, market segments, application areas, and market growth strategies.